Today Canadian Medical Cannabis Council (CMCC) Interim Executive Director Philippe Lucas offered the following remarks in response to Health Canada’s decision to allow legal production of medical cannabis oils by licensed producers under the Controlled Drugs and Substances Act (CDSA):

  • “The Canadian Medical Cannabis Council applauds Health Canada’s response to the recent Supreme Court ruling that found authorized patients have a constitutional right to possess non-dried forms of medical cannabis—including oils and extracts.”
  • “The availability of standardized, labelled and quality-tested oil and extract products will help meet physician and patient requests for a more predictable dosage and potentially safer medical cannabis delivery and ingestion methods.”
  • “We are looking forward to working with medical cannabis patients, researchers, licensed producers and the government to expedite legal access to cannabis oils and extracts over the next few weeks.”
  •  “We believe this change will go a long way to addressing the needs of patients who would rather not smoke cannabis to alleviate their symptoms and conditions.”
  • “Looking at other jurisdictions outside of Canada, we’ve seen what can happen when extracts and derivatives are not properly regulated. Since Canada already has stringent medical cannabis regulations with the Marihuana for Medical Purposes Regulations (MMPR), it makes sense that extracts should be regulated in a similar manner to ensure patient safety and product quality.”